Cell Polarity Factor Par3 Binds SPTLC1 and Modulates Monocyte Serine Palmitoyltransferase Activity and Chemotaxis

Abstract

Elevated sphingolipids have been associated with increased cardiovascular disease. Conversely, atherosclerosis is reduced in mice by blocking de novo synthesis of sphingolipids catalyzed by serine palmitoyltransferase (SPT). The SPT enzyme is composed of the SPTLC1 and -2 subunits, and here we describe a novel protein-protein interaction between SPTLC1 and the PDZ protein Par3 (partitioning defective protein 3). Mammalian SPTLC1 orthologs have a highly conserved C terminus that conforms to a type II PDZ protein interaction motif, and by screening PDZ domain protein arrays with an SPTLC1 C-terminal peptide, we found it bound the third PDZ domain of Par3. Overlay and immunoprecipitation assays confirmed this interaction and indicate Par3 is able to associate with the SPTLC1/2 holoenzyme by binding the C-terminal SPTLC1 PDZ motif. The physiologic existence of the SPTLC1/2-Par3 complex was detected in mouse liver and macrophages, and short interfering RNA inhibition of Par3 in human THP-1 monocytes significantly reduced SPT activity and de novo ceramide synthesis by nearly 40%. Given monocyte recruitment into inflamed vessels is thought to promote atherosclerosis, and because Par3 and sphingolipids have been associated with polarized cell migration, we tested whether the ability of THP-1 monocytes to migrate toward MCP-1 (monocyte chemoattractant protein 1) depended upon Par3 and SPTLC1 expression. Knockdown of Par3 significantly reduced MCP1-induced chemotaxis of THP-1 monocytes, as did knockdown of SPTLC1, and this Par3 effect depended upon SPT activity and was blunted by ceramide treatment. In conclusion, protein arrays were used to identify a novel SPTLC1-Par3 interaction that associates with increased monocyte serine palmitoyltransferase activity and chemotaxis toward inflammatory signals.Sphingolipids are a structurally diverse class of lipids that play correspondingly diverse roles in membrane structure, cell proliferation, immune function, and skin physiology (1-4). De novo sphingolipid synthesis is initiated by serine palmitoyltransferase (SPT), 2 an enzyme that condenses serine and palmitoyl-CoA forming the biosynthetic intermediate 3-ketodihydrosphingosine that is subsequently converted to ceramide, sphingomyelin, and other sphingolipids (5). SPT is a heterodimer composed of the SPTLC1 and -2 subunits (6, 7), which may form higher order multimeric structures that can include a third subunit, SPTLC3 (8, 9). Both the SPTLC2 and -3 subunits are catalytically active and contain conserved lysines that act as Schiff bases during the condensation reaction (5, 8). In contrast, SPTLC1 does not contain the conserved catalytically active lysine, but is important for stabilizing the SPTLC2 subunit and anchoring the SPT holoenyzme on the cytosolic face of the endoplasmic reticulum (10, 11).Expression and regulation of the SPTLC1/2 holoenyzme are of interest because its activity controls de novo synthesis of sphingomyelin, and increased plasma levels of this sphingolipid have been correlated with an increased incidence...

Nutrient Modification of the Innate Immune Response

“…For example, whereas we successfully used siRNA to knock-down TLR4, our attempts to use siRNA against serine palmitoyltransferase consistently led to considerable cell death and a minimally effective knockdown in the remaining cells. Consistent with our experience, Tamehiro et al 42 still needed to use Myricin to achieve substantial inhibition of ceramide synthesis even in THP-1 cells selected (using puromycin) for successful transfection and expression of lentiviral shRNA against this enzyme. To overcome these difficulties, we studied this pathway using multiple, functionally unrelated inhibitors.…”

Liver serine palmitoyltransferase activity deficiency in early life impairs adherens junctions and promotes tumorigenesis

“…Because all cell membranes that define cell boundaries and polarity contain lipid bilayer structures, we hypothesized that the lipid, especially the sphingolipid, environment could influence polarity. Indeed, the Sptlc1/2 complex can bind cell polarity factor Par3 and modulate monocyte polarity and migration …”

Mammalian ORMDL Proteins Mediate the Feedback Response in Ceramide Biosynthesis

“…3). Additionally, regulatory subunits have also been reported (4,5). In yeast, Orm proteins (Orm1 and -2) associate with SPT and negatively regulate SPT activity in response to changes in cellular ceramide levels (6 -8).…”